Oppenheimer, Pure Storage

In a report released today, Francois Brisebois from Oppenheimer maintained a Hold rating on Ovid Therapeutics (OVID – Research Report).
The Rock's filmography has been tough sledding in recent years and his latest Christmas-themed project seems to be more of ...
Brian Nagel, Oppenheimer senior analyst, joins 'Squawk Box' to break down Home Depot's Q3 earnings results. Posted: November ...
Greece’s Thessaloniki Film Festival ends this evening with a screening of The End, the latest feature project from the ...
The Rock can always put a wildly positive spin on any of his movies, but his latest promotional clip takes the cake: he’s ...
Oppenheimer's Limited-Edition Steelbook releases November 19 and comes with 4K and standard Blu-ray discs as well as a ...
NEW YORK, Nov. 14, 2024 /PRNewswire/ -- Pontera™, the fintech company helping retirement savers receive professional 401 (k) ...
Oppenheimer analyst Rick Schafer raised the firm’s price target on Nvidia (NVDA) to $175 from $150 and keeps an Outperform rating on the ...